Sara Pellegrino | executive |
Frederick Vogt | executive |
Igor Bilinsky | executive |
James Ziegler | executive |
Friedrich Graf Finckenstein | executive |
Jean-Marc Bellemin | executive |
Peter Lawson | analyst |
Colleen Hanley | analyst |
Yanan Zhu | analyst |
Raj Puri | executive |
Dina Elmonshed | analyst |
Reni Benjamin | analyst |
Mara Goldstein | analyst |
Karina Rabayeva | analyst |
Benjamin Burnett | analyst |
Kelsey Goodwin | analyst |
Welcome to the Iovance Biotherapeutics Third Quarter and Year-to-Date 2023 Financial Results and Corporate Update Conference Call. My name is Abigail, and I will be your operator for today's call. [Operator Instructions] Please note that this conference is being recorded. I will now turn the call over to Sara Pellegrino, Senior Vice President, Investor Relations and Corporate Communications at Iovance. Sarah, you may begin.